Ionis Pharmaceuticals Inc — 四半期貸借対照表 (NASDAQ:IONS) | MetaTrader

チャート全体を表示

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

ニュース

Rare Stock Picks In March 2026 - From 23 Discerning Analysts

Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug

Ionis Pharmaceuticals' Peak Olezarsen Revenues Are Likely Very Conservative (NASDAQ:IONS)

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Ionis Pharmaceuticals, Inc. (IONS) Presents at Stifel 2026 Virtual CNS Forum Transcript

キャシー・ウッドのARK、CRISPR株を買い増し、10x Genomicsを売却

ウルフ・リサーチ、アクティビスト誘引度スコアが最も高い12社を特定

Wolfe Research identifies 12 companies with highest activist attractiveness scores

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS - TipRanks.com

キャシー・ウッドのARK株式取引、CRSPとPAYPが最大の買い、TERとIONSを売却

Cathie Wood’s ARK stock trades: CRSP and PAYP top buys, TER and IONS sold